- This event has passed.
Developing Alternative Administration Techniques for Therapeutics and Vaccines – Hosted by JLABS
February 23, 2021 @ 11:00 am - 12:30 pm
Expanding the mechanisms for administering therapeutics and vaccines may have the potential to disrupt the status quo and improve availability and accessibility of therapeutic and preventive treatments. This session will explore opportunities for alternative delivery mechanisms and novel innovations which aim to provide alternative methods of administration, including micro-array patches and nasal and oral/sublingual administration.
Experts in the field will explore current innovations in the space, what the future may look like, and how novel administration methods may help overcome the logistical burden that is commonly associated with traditional techniques. New mechanisms can produce new challenges but may also have the potential to ease administration, reduce dosing requirements, improve stability, provide a slow release for greater efficacy, and ultimately improve availability of vaccines and therapeutics.
11:00 AM Opening Remarks
Stephen Pitt | Regional Head, JLABS @ US North East, Johnson & Johnson Innovation
Sally Allain | Regional Head, JLABS @ Washington, DC, Johnson & Johnson Innovation
11:15 AM Presentations
Tanima Sinha | Lead Interdisciplinary Scientist, BARDA
Barbara Hibner | SVP and Head of R&D, Decoy Therapeutics
Mark Prausnitz | Regents’ Professor and J. Erskine Love, Jr. Chair of Chemical & Biomolecular Engineering at the Georgia Institute of Technology
11:45 AM Panel Discussion
Nicola La Monica | Senior Director of Infectious Diseases and Vaccines Scientific Innovation, Johnson & Johnson (Moderator)
Tanima Sinha | Lead Interdisciplinary Scientist, BARDA
Barbara Hibner | SVP and Head of R&D, Decoy Therapeutics
Mark Prausnitz | Regents’ Professor and J. Erskine Love, Jr. Chair of Chemical & Biomolecular Engineering at the Georgia Institute of Technology
12:15 PM Audience Q&A
*This program is part of BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA).